首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3241篇
  免费   241篇
  国内免费   31篇
耳鼻咽喉   74篇
儿科学   61篇
妇产科学   77篇
基础医学   492篇
口腔科学   45篇
临床医学   286篇
内科学   755篇
皮肤病学   44篇
神经病学   251篇
特种医学   214篇
外科学   426篇
综合类   104篇
一般理论   2篇
预防医学   155篇
眼科学   26篇
药学   309篇
中国医学   8篇
肿瘤学   184篇
  2023年   19篇
  2022年   47篇
  2021年   108篇
  2020年   49篇
  2019年   64篇
  2018年   86篇
  2017年   67篇
  2016年   73篇
  2015年   78篇
  2014年   116篇
  2013年   174篇
  2012年   261篇
  2011年   285篇
  2010年   157篇
  2009年   117篇
  2008年   206篇
  2007年   215篇
  2006年   214篇
  2005年   165篇
  2004年   179篇
  2003年   155篇
  2002年   144篇
  2001年   36篇
  2000年   37篇
  1999年   37篇
  1998年   22篇
  1997年   27篇
  1996年   22篇
  1995年   19篇
  1994年   8篇
  1993年   9篇
  1992年   24篇
  1991年   22篇
  1990年   17篇
  1989年   17篇
  1988年   14篇
  1987年   17篇
  1986年   16篇
  1985年   27篇
  1984年   14篇
  1983年   17篇
  1982年   11篇
  1981年   10篇
  1980年   13篇
  1978年   8篇
  1976年   9篇
  1975年   12篇
  1974年   9篇
  1973年   10篇
  1972年   7篇
排序方式: 共有3513条查询结果,搜索用时 31 毫秒
991.
OBJECTIVE: This study investigated the possible linkage of intracerebrally recorded P3-like waveforms to the processes induced by stimulus perception or motor response formation. METHODS: Event-related potentials were recorded from 560 cerebral sites in 17 patients suffering from intractable epilepsy during visual oddball task. Potentials evoked by the target stimuli were sorted according to button-pressing response times, and the P3 waveform was analyzed both in stimulus-locked and response-locked averages, which were separately averaged for fast and slow responses. RESULTS: P3-like waveforms were identified in 180 sites in 17 patients. Three different types of P3-like waveforms, diffusely distributed within the brain, were found: (1) time-locked to the stimulus (30 sites in 11 patients); (2) time-locked to the motor response (52 sites in 13 patients); and (3) with ambiguous time relationship to stimulus and motor response (98 sites in 16 patients). CONCLUSIONS: The intracerebral P3-like waveform could represent different processes involved in performing active oddball tasks. Therefore, our results support the hypothesis that the P3 waveform registered by surface electrodes could be a heterogeneous phenomenon. SIGNIFICANCE: These results provide evidence that the P3 waveform is not only related to stimulus processing, which differs from what has been generally claimed in the literature.  相似文献   
992.
Human trophoblast populations from first- and third-trimester placentas produce interferons (IFNs) in the presence of growth factors (CSF and PDGF) or when infected with virus. The highly invasive extravillous trophoblast population produced a higher level of IFNs (three- to eightfold, P < 0.05) than the noninvasive villous trophoblast population when stimulated with growth factors and/or virus. The level of IFN produced was dependent on the type of trophoblast population, the type of inducer and the stage of differentiation of the trophoblasts. Tandem immunoaffinity chromatography of the virus-induced trophoblast IFNs resulted in the isolation of trophoblast IFN-α and -β types. The purified trophoblast IFNs have antiviral, antiproliferative and immunoregulatory properties. Furthermore, the trophoblast IFNs inhibited the expression of proto-oncogenes such as EGF-R, c-erbB2 and c-fms reported to be involved in normal trophoblast growth and differentiation. These data suggest essential roles of interferons in normal human development during pregnancy.  相似文献   
993.
We have conducted a phase I study to evaluate the toxicity and tolerance of a 5 day continuous infusion of spirogermanium and 5-fluorouracil, (5-FU). The 5-FU was administered via a peripheral vein at 1000 mg/M2/day for 5 days by continuous infusion. Simultaneously, spirogermanium was administered via an indwelling central venous catheter by continuous infusion for 5 days starting at 50 mg/M2/day and escalating to 250 mg/M2/day. Sixteen patients received a total of 54.5 courses of therapy. The most common and severe toxicity was neurotoxicity. Mild to moderate gastrointestinal toxicity also occurred. No significant hematologic toxicity occurred. Two partial responses occurred lasting 11 and 20.5 months, both at the 100 mg/M2/day level of spirogermanium. The recommended phase II dosages are 5-FU 1000 mg/M2/day and spirogermanium 200 mg/M2/day by 5 day continuous infusion with escalation of the spirogermanium in selected individuals. Patients on long term therapy should have close neurologic evaluation and follow up. Consideration should also be given to evaluating a group of patients at the 100 mg/M2/day level of spirogermanium due to the responses seen at this level.Presented in part at the 79th annual meeting of the American Association for Cancer Research, May 1988, New Orleans, LA, USA.  相似文献   
994.
We compared the survival of 842 patients on centre haemodialysis to 272 patients on continuous ambulatory peritoneal dialysis (CAPD). All patients selected had begun treatment between 1 January 1984 and 30 June 1988 and were from six centres which participate in a regional renal patients registry. Patients on CAPD were older and had a greater proportion of diabetes and other associated diseases. Age, diabetes, and cardiovascular diseases were associated with a shorter survival on treatment in all the patients studied. Without adjustment for risk factors, patient 3-year survival was higher in centre haemodialysis than in CAPD, 80% versus 64% respectively. However, no significant differences could be shown in the survival rates of the two treatment modalities after accounting for the heterogeneity of the patients in the two groups, either by stratification or by multivariate analysis (Cox). Age was the main predictive factor for CAPD patient survival, while the influence of diabetes and cardiovascular diseases was less clear. Technique survival was much better in centre haemodialysis (94% versus 56% in CAPD, 3-year survival). Older age and diabetes mellitus were associated with a greater risk of switching from centre haemodialysis to CAPD and a trend to retain those patients on CAPD.  相似文献   
995.
This is a retrospective case series reporting lactic acidosis in four pediatric patients with acute severe asthma treated with nebulized beta2-agonists in a pediatric intensive care unit of a tertiary care teaching facility. During treatment with beta2-agonists, these patients developed lactic acidosis with a peak concentration of 5.2 to 13 mmol/l. Lactic acidosis improved within 24 h after discontinuation or decrease in the dosage of beta2-agonists. We conclude that the intensive use of beta2-agonists for acute severe asthma in children may be the primary and significant cause of lactic acidosis.  相似文献   
996.
997.
998.
999.
OBJECTIVE: To analyze the possible association between insulin resistance and dyslipidemia with uterine fibroids, using objective metabolic measurements. METHOD: A cross-sectional study of 56 women with uterine fibroids (case group) and 20 women without fibroids (control group). Levels of fasting glucose, insulin, C-peptide, sex hormone-binding globulin, and the lipid panel were measured. The short insulin tolerance test was performed. Body mass index, atherogenic index, and the indicator of insulin resistance (Kitt) were also calculated. RESULTS: Women with fibroids had significantly higher levels of serum HDL-cholesterol compared with control patients (1.8+/-0.3 vs 1.6+/-0.5; P<0.05). Women with fibroids aged 30-45 years had significantly lower LDL-cholesterol levels than comparative control patients (2.9+/-0.7 vs 3.4+/-0.9; P<0.05). A positive correlation between volume of the largest fibroid and serum HDL-cholesterol level was found in women aged 30-45 years. There were no differences in indicators of insulin resistance between the groups. CONCLUSION: Insulin resistance was not shown to be a risk factor for fibroids. There is a negative association between some parameters of metabolic syndrome and fibroid volume.  相似文献   
1000.
BACKGROUND AND PURPOSE: Adaptive image-guided IMRT appears to be a promising approach for dose escalation in pharyngo-laryngeal tumors. In this framework, we assessed in a proof of concept study the impact of anatomic and functional imaging modalities acquired prior and during radiotherapy on the target volume delineation and the dose distribution using helical tomotherapy. MATERIALS AND METHODS: Ten patients with pharyngo-laryngeal squamous cell carcinoma were treated by concomitant chemo-radiation delivered in 7 weeks. CT, T2-MRI, fat suppressed T2-MRI, and static and dynamic FDG-PET were acquired for each patient before the start of treatment and during radiotherapy, after mean prescribed doses of 14, 25, 35 and 45 Gy. GTVs were manually delineated on CT and MRI images while PET images were automatically segmented by means of a gradient-based method. From these volumes, CTVs and PTVs were derived using consistent guidelines. Simultaneous integrated boost IMRT planning was performed using helical tomotherapy. RESULTS: GTVs significantly decreased throughout the course of RT for all imaging modalities (p<0.001). Clinically non-significant differences and high correlations were found between GTVs delineated on CT and MRI, irrespective of the sequence used. By contrast, FDG-PET-based GTVs segmented from pre- and per-treatment images were significantly smaller compared to anatomical imaging modalities, without any difference existing between static and dynamic acquisition. These differences in GTVs translated into parallel reductions of both prophylactic and therapeutic CTVs and PTVs. Resulting FDG-PET-based and adaptive IMRT planning reduced the irradiated volumes by 15-40% compared to pre-treatment CT planning (V(90), V(95) and V(100)), but did marginally impact on doses to the OAR such as the spinal cord and the parotid glands. CONCLUSIONS: Adaptive IMRT with FDG-PET images has a significant impact on the delineation of TVs and on the dose distribution in pharyngo-laryngeal tumors. Such an approach might thus be considered for dose escalation strategies.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号